TATAA Biocenter
PrivateLast Round
VC Round
Oct 1, 2023
Company Overview
TATAA Biocenter is a biotechnology company that provides molecular analysis services, including qPCR, dPCR, NGS, and proteomics, to support drug development and clinical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TATAA Biocenter Comparables
Compare TATAA Biocenter with similar companies based on industry and business-model similarity.
TATAA Biocenter Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 1, 2023 | ||||
| Grant | Oct 20, 2022 | ||||
| Private Equity | Apr 30, 2021 |
TATAA Biocenter Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vinnova | Grant |
| Care Equity | Private Equity, VC Round |
TATAA Biocenter Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TATAA Biocenter's valuation, stock price, and market status.